KürzelAnalyseMaterial
ASUArsen i.HarnMATERIAL: Spontanharn, METHODE: AAS
AT3Antithrombin IIIMATERIAL: Citrat, METHODE: chromogenes Substrat
ATOMOXETINAtomoxetinMATERIAL: Serum, METHODE:
ATPATP intracellulärMATERIAL: Heparinblut; Methode: CLIA
ATRYPA1-AntitrypsinMATERIAL: Serum, METHODE: turbidimetrisch
ATRYPGENA1-Antitrypsin GenotypMATERIAL: EDTA, Methode: molekulargenetischer Nachweis
ATRYPPHA1-Antitrypsin-PhänotypMATERIAL: Serum
ATRYPSTA1-Antitrypsin im StuhlMATERIAL: Stuhl
B1ADREZAKBeta 1 adrenerge Rezeptor AKMATERIAL: Serum, Methode: ELISA
B2ADREZAKBeta 2 adrenerge Rezeptor AKMATERIAL: Serum, Methode: ELISA
B2GPGBeta-2-Glykoprotein IgGMATERIAL: Serum, METHODE: ELISA
B2GPMBeta-2-Glykoprotein IgMMATERIAL: Serum, METHODE: ELISA
B2MGBeta-2-MikroglobulinMATERIAL: Serum, METHODE: MEIA
B2MGUBeta-2-Mikroglobulin i.HarnMATERIAL: Spontanharn, METHODE: MEIA
B5UPantothensäure i.HarnMATERIAL: 24h-Sammelharn, METHODE: HPLC
BABarium im SerumMATERIAL: Serum, METHODE: AAS
BABDIVGBabesia divergens IgG-AKMATERIAL: Serum; Methode: IFT
BABMICGBabesia microti IgG-AKMATERIAL: Serum; Methode: IFT
BABSB-Zellen absolutMATERIAL: EDTA, METHODE: Flow cytometrie
BACLOFENBaclofenMATERIAL: Serum, METHODE: LC-MS